Citation Impact
Citing Papers
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Emergence of High-Avidity Melan-A–Specific Clonotypes as a Reflection of Anti–PD-1 Clinical Efficacy
2017
Multiphoton Phosphorescence Quenching Microscopy Reveals Kinetics of Tumor Oxygenation during Antiangiogenesis and Angiotensin Signaling Inhibition
2022 StandoutNobel
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
2017 Science
TCR-like CARs and TCR-CARs targeting neoepitopes: an emerging potential
2021
Development and Preliminary Clinical Activity of PD-1-Guided CTLA-4 Blocking Bispecific DART Molecule
2020
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
2018 StandoutNobel
Current and emerging systemic therapies for cutaneous metastatic melanoma
2019
T cell-targeting nanoparticles focus delivery of immunotherapy to improve antitumor immunity
2017
Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy
2016
Targeted glycan degradation potentiates the anticancer immune response in vivo
2020 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy
2022 StandoutNobel
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
2020 Standout
Regulatory T cells in tumor microenvironment: new mechanisms, potential therapeutic strategies and future prospects
2020
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Engineering precision nanoparticles for drug delivery
2020 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Genome-Editing Technologies in Adoptive T Cell Immunotherapy for Cancer
2017
Top 10 Challenges in Cancer Immunotherapy
2020
A view on drug resistance in cancer
2019 StandoutNature
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
2018
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
2017
T cell receptor sequencing of activated CD8 T cells in the blood identifies tumor-infiltrating clones that expand after PD-1 therapy and radiation in a melanoma patient
2018
Hydroxycholesterol substitution in ionizable lipid nanoparticles for mRNA delivery to T cells
2022 StandoutNobel
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
Hepatocellular carcinoma
2021 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Post-Translational Peptide Splicing and T Cell Responses
2017
Organoid Models of Tumor Immunology
2020
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
2020
RAS-targeted therapies: is the undruggable drugged?
2020
Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine
2016
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
2021 StandoutNobel
Delivery technologies for cancer immunotherapy
2019 Standout
Improving cancer immunotherapy through nanotechnology
2019
Colorectal cancer
2019 Standout
Mitochondrial dysregulation and glycolytic insufficiency functionally impair CD8 T cells infiltrating human renal cell carcinoma
2017
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
2018
Immunotherapy in colorectal cancer: rationale, challenges and potential
2019
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
2016 Standout
Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
2017
CAR T Cells for Solid Tumors: New Strategies for Finding, Infiltrating, and Surviving in the Tumor Microenvironment
2019
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Targeting neoantigens to augment antitumour immunity
2017
The immunobiology of hepatocellular carcinoma in humans and mice: Basic concepts and therapeutic implications
2019
Regulation and Function of the PD-L1 Checkpoint
2018 Standout
T cell antigen discovery via trogocytosis
2019 Nobel
Role of PD-1 in Immunity and Diseases
2017 StandoutNobel
Neoantigen Targeting—Dawn of a New Era in Cancer Immunotherapy?
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals
2020 Standout
Oxidative Stress in Cancer
2020 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Engineering patient-specific cancer immunotherapies
2019
Radiotherapy: Changing the Game in Immunotherapy
2016
Delivery technologies for T cell gene editing: Applications in cancer immunotherapy
2021
CD8+ T cell states in human cancer: insights from single-cell analysis
2020
Coinhibitory Receptor Expression and Immune Checkpoint Blockade: Maintaining a Balance in CD8+ T Cell Responses to Chronic Viral Infections and Cancer
2017 StandoutNobel
CD8+ T cell differentiation and dysfunction in cancer
2021
Targeting autophagy in cancer
2017 Standout
Targeting ferroptosis as a vulnerability in cancer
2022 Standout
Neoantigen Vaccine Delivery for Personalized Anticancer Immunotherapy
2018
Immune targets and neoantigens for cancer immunotherapy and precision medicine
2016
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Immune escape to PD-L1/PD-1 blockade: seven steps to success (or failure)
2016
Monitoring immune responses in the tumor microenvironment
2016
CD4+ T cell help in cancer immunology and immunotherapy
2018
Opportunities for Treg cell therapy for the treatment of human disease
2023 StandoutNobel
Combined treatment with ipilimumab and intratumoral interleukin-2 in pretreated patients with stage IV melanoma—safety and efficacy in a phase II study
2016
Recent Advances in Targeting CD8 T-Cell Immunity for More Effective Cancer Immunotherapy
2018
Metabolic Regulation of T Cell Longevity and Function in Tumor Immunotherapy
2017
A guide to cancer immunotherapy: from T cell basic science to clinical practice
2020 Standout
Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and Cancer
2019 StandoutNobel
Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response
2018 Standout
Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
2023 StandoutNobel
Atezolizumab for First-Line Treatment of Metastatic Nonsquamous NSCLC
2018 Standout
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
2013 StandoutNobel
Immunotherapy for Colorectal Cancer
2017
In Vivo mRNA CAR T Cell Engineering via Targeted Ionizable Lipid Nanoparticles with Extrahepatic Tropism
2023 StandoutNobel
Successive annual influenza vaccination induces a recurrent oligoclonotypic memory response in circulating T follicular helper cells
2017
Chimeric antigen receptor–modified T cells: CD19 and the road beyond
2018
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
2018 StandoutNobel
Regulatory T (Treg) cells in cancer: Can Treg cells be a new therapeutic target?
2019
Chimeric Antigen Receptor Therapy
2018 Standout
Shaping of T Cell Functions by Trogocytosis
2021
Metabolic reprogramming and cancer progression
2020 StandoutScience
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Native Folding of a Recombinant gpE1/gpE2 Heterodimer Vaccine Antigen from a Precursor Protein Fused with Fc IgG
2016 StandoutNobel
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
2017
Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells
2021 StandoutNobel
Therapeutic cancer vaccines
2015
Cancer immunotherapy using checkpoint blockade
2018 StandoutScience
A tumor-specific mechanism of T reg enrichment mediated by the integrin αvβ8
2021
Emerging concepts in immunity to hepatitis C virus infection
2013
Works of Anna Pasetto being referenced
Isolation of T-Cell Receptors Specifically Reactive with Mutated Tumor-Associated Antigens from Tumor-Infiltrating Lymphocytes Based on CD137 Expression
2016
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancer
2017 Science
T-cell Responses to TP53 “Hotspot” Mutations and Unique Neoantigens Expressed by Human Ovarian Cancers
2018
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh Tumor
2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor Antigens
2016
Stable, Nonviral Expression of Mutated Tumor Neoantigen-specific T-cell Receptors Using the Sleeping Beauty Transposon/Transposase System
2016
Memory T cells targeting oncogenic mutations detected in peripheral blood of epithelial cancer patients
2019
Neoantigen screening identifies broad TP53 mutant immunogenicity in patients with epithelial cancers
2019
Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
2018
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients
2016
Recognition of human gastrointestinal cancer neoantigens by circulating PD-1+ lymphocytes
2019
T-Cell Transfer Therapy Targeting Mutant KRAS in Cancer
2016
Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy
2018
A Pilot Trial of the Combination of Vemurafenib with Adoptive Cell Therapy in Patients with Metastatic Melanoma
2016
TCR-Redirected Human T Cells Inhibit Hepatitis C Virus Replication: Hepatotoxic Potential Is Linked to Antigen Specificity and Functional Avidity
2012
Tumor-infiltrating human CD4 + regulatory T cells display a distinct TCR repertoire and exhibit tumor and neoantigen reactivity
2019